These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 19202566)
1. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation? Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566 [TBL] [Abstract][Full Text] [Related]
2. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858 [TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462 [TBL] [Abstract][Full Text] [Related]
4. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733 [TBL] [Abstract][Full Text] [Related]
5. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system. Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848 [TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome. Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050 [TBL] [Abstract][Full Text] [Related]
7. Timing of radiation in children with medulloblastoma/PNET. Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032 [TBL] [Abstract][Full Text] [Related]
8. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826 [TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET. Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071 [TBL] [Abstract][Full Text] [Related]
10. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801 [TBL] [Abstract][Full Text] [Related]
11. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Chintagumpala M; Hassall T; Palmer S; Ashley D; Wallace D; Kasow K; Merchant TE; Krasin MJ; Dauser R; Boop F; Krance R; Woo S; Cheuk R; Lau C; Gilbertson R; Gajjar A Neuro Oncol; 2009 Feb; 11(1):33-40. PubMed ID: 18796696 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study. Fouladi M; Blaney SM; Poussaint TY; Freeman BB; McLendon R; Fuller C; Adesina AM; Hancock ML; Danks MK; Stewart C; Boyett JM; Gajjar A Cancer; 2006 Nov; 107(9):2291-7. PubMed ID: 17019740 [TBL] [Abstract][Full Text] [Related]
16. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538 [TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group. Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363 [TBL] [Abstract][Full Text] [Related]
18. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors. McBride SM; Daganzo SM; Banerjee A; Gupta N; Lamborn KR; Prados MD; Berger MS; Wara WM; Haas-Kogan DA Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1319-23. PubMed ID: 18485615 [TBL] [Abstract][Full Text] [Related]
19. Survival of adults treated for medulloblastoma using paediatric protocols. Spreafico F; Massimino M; Gandola L; Cefalo G; Mazza E; Landonio G; Pignoli E; Poggi G; Terenziani M; Pedrazzoli P; Siena S; Fossati-Bellani F Eur J Cancer; 2005 Jun; 41(9):1304-10. PubMed ID: 15869875 [TBL] [Abstract][Full Text] [Related]
20. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Pizer BL; Weston CL; Robinson KJ; Ellison DW; Ironside J; Saran F; Lashford LS; Tait D; Lucraft H; Walker DA; Bailey CC; Taylor RE Eur J Cancer; 2006 May; 42(8):1120-8. PubMed ID: 16632346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]